Retatrutide 10mg (Bacteriostatic water not included)

Retatrutide is an investigational peptide currently being studied for its potential effects on metabolic health and weight management. It is a triple receptor agonist, meaning it acts on three key hormone receptors involved in energy balance and glucose regulation.

Key Mechanisms of Action

Retatrutide targets:

• GLP-1 (Glucagon-Like Peptide-1) receptor

• GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor

• Glucagon receptor

By engaging all three pathways, retatrutide is designed to influence:

• Appetite regulation

• Energy expenditure

• Fat metabolism

• Blood glucose control

Research Focus

Clinical research is currently exploring retatrutide for:

• Obesity and weight management

• Insulin sensitivity

• Metabolic syndrome

• Type 2 diabetes–related metabolic pathways

Early trial data has shown significant reductions in body weight and improvements in metabolic markers when compared to single- or dual-agonist compounds.

10 mg Strength

• The 10 mg designation refers to the total peptide content per vial.

• Concentration and use depend on formulation and research protocols.

• Retatrutide at this strength is typically intended for research or investigational purposes only.

Important Notes

• Retatrutide is not FDA-approved for general medical use.

• It is not intended to diagnose, treat, cure, or prevent any disease.

• Use should be limited to qualified research settings or under medical supervision.

• Safety, long-term effects, and optimal protocols are still under investigation.

Storage (General)

• Typically stored in a cool, dry environment

• May require refrigeration after reconstitution, depending on formulation

• Always follow manufacturer or research-grade handling guidelines